Table 6.

Resection limit status in the untreated and treated patients with clinical stage B disease

	Surgery only (%)	12 weeks of NHT (%)	24 weeks of NHT (%)
Negative margins	53 (53.5%)	80 (74.1%)	74 (81.3%)
Positive margins	46 (46.5%)	28 (25.9%)	17 (18.7%)

Chi square=18.953; p<0.001. Untreated versus 12 weeks of NHT: χ²=8.613; p=0.003. Untreated versus 24 weeks of NHT: χ²=15.284; p<0.001. 12 weeks of NHT versus 24 weeks of NHT: χ²=1.096; p=0.295 (not significant).

NHT, neoadjuvant hormonal treatment.